Versant Side Fund IV, L.P.

10% owner at Contineum Therapeutics, Inc. · on record since Apr 11, 2024
10% owner at Clovis Oncology, Inc. · on record since Nov 17, 2011
10% owner at CRISPR Therapeutics AG · on record since Oct 26, 2016
10% owner at LOT78, INC. · on record since Jul 19, 2016
10% owner at IVERIC bio, Inc. · on record since Nov 9, 2018
10% owner at Oyster Point Pharma, Inc. · on record since Oct 30, 2019
10% owner at Inari Medical, Inc. · on record since May 27, 2020
10% owner at EMERGING VISION INC · on record since Jun 23, 2020
10% owner at Tempest Therapeutics, Inc. · on record since Jul 6, 2021

Insider trading activity of Versant Side Fund IV, L.P.

Transactions on record: 37; since Jun 5, 2013

Open-market buys: 3; $9.4M

Open-market sells: 0

Companies traded: 4; last filing May 14, 2021

Figures computed from official regulatory filings — .

Companies where Versant Side Fund IV, L.P. has traded

Oyster Point Pharma, Inc.17 tx · $9.4M · May 14, 2021
IVERIC bio, Inc.2 tx · $300.2K · Jan 16, 2019
CRISPR Therapeutics AG16 tx · $2.3M · Sep 7, 2017
Clovis Oncology, Inc.2 tx · Jun 5, 2013

Track record of Versant Side Fund IV, L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Versant Side Fund IV, L.P.

Co-insiders of Versant Side Fund IV, L.P.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Oyster Point Pharma, Inc.Listing unverified	May 14, 2021	Other	82,486	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oyster Point Pharma, Inc.Listing unverified	May 14, 2021	Other	-320,340	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oyster Point Pharma, Inc.Listing unverified	May 14, 2021	Other	-82,486	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oyster Point Pharma, Inc.Listing unverified	May 14, 2021	Other	-2,018	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	Other	1,654,359	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	OtherD (derivative)	-495,388	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	Other	10,420	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	Other	495,388	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	Buy	125,000	16.00 USD	$2M	conv 52ClusterFirst in 12mo	SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	Buy	437,500	16.00 USD	$7M	conv 77ClusterFirst in 12mo	SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	Other	566,158	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	OtherD (derivative)	-10,420	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	Other	1,941,500	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	OtherD (derivative)	-566,158	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	Buy	27,500	16.00 USD	$440K	conv 50ClusterFirst in 12mo	SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	OtherD (derivative)	-1,654,359	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	OtherD (derivative)	-1,941,500	—	n/a (No price was disclosed in the filing)		SEC
IVERIC bio, Inc.Listing unverified	Jan 16, 2019	Other	817	2.30 USD	$1.9K		SEC
IVERIC bio, Inc.Listing unverified	Jan 16, 2019	Other	129,709	2.30 USD	$298.3K		SEC
CRISPR Therapeutics AGListing on record	Sep 7, 2017	Other	17,283	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRISPR Therapeutics AGListing on record	Sep 7, 2017	Other	-8,110	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRISPR Therapeutics AGListing on record	Sep 7, 2017	Other	-1,240	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRISPR Therapeutics AGListing on record	Sep 7, 2017	Other	-814,599	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRISPR Therapeutics AGListing on record	Sep 7, 2017	Other	1,240	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRISPR Therapeutics AGListing on record	Sep 7, 2017	Other	-61,993	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Oyster Point Pharma, Inc.Listing unverified	May 14, 2021	Other	82,486	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oyster Point Pharma, Inc.Listing unverified	May 14, 2021	Other	-320,340	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oyster Point Pharma, Inc.Listing unverified	May 14, 2021	Other	-82,486	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oyster Point Pharma, Inc.Listing unverified	May 14, 2021	Other	-2,018	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	Other	1,654,359	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	OtherD (derivative)	-495,388	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	Other	10,420	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	Other	495,388	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	Buy	125,000	16.00 USD	$2M	conv 52ClusterFirst in 12mo	SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	Buy	437,500	16.00 USD	$7M	conv 77ClusterFirst in 12mo	SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	Other	566,158	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	OtherD (derivative)	-10,420	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	Other	1,941,500	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	OtherD (derivative)	-566,158	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	Buy	27,500	16.00 USD	$440K	conv 50ClusterFirst in 12mo	SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	OtherD (derivative)	-1,654,359	—	n/a (No price was disclosed in the filing)		SEC
Oyster Point Pharma, Inc.Listing unverified	Nov 4, 2019	OtherD (derivative)	-1,941,500	—	n/a (No price was disclosed in the filing)		SEC
IVERIC bio, Inc.Listing unverified	Jan 16, 2019	Other	817	2.30 USD	$1.9K		SEC
IVERIC bio, Inc.Listing unverified	Jan 16, 2019	Other	129,709	2.30 USD	$298.3K		SEC
CRISPR Therapeutics AGListing on record	Sep 7, 2017	Other	17,283	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRISPR Therapeutics AGListing on record	Sep 7, 2017	Other	-8,110	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRISPR Therapeutics AGListing on record	Sep 7, 2017	Other	-1,240	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRISPR Therapeutics AGListing on record	Sep 7, 2017	Other	-814,599	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRISPR Therapeutics AGListing on record	Sep 7, 2017	Other	1,240	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRISPR Therapeutics AGListing on record	Sep 7, 2017	Other	-61,993	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC